Molecular Partners Ag (MOLN) EV to CFO (2021 - 2026)
Molecular Partners Ag's (MOLN) quarterly EV to CFO came in at 2.22 in Q2 2026, down 408.82% year-over-year from 0.72 in Q2 2025, and up 99.93% quarter-over-quarter from 3280.11 in Q1 2026.
Powered by 
Analysis
Molecular Partners Ag (MOLN) EV to CFO (2021 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported EV to CFO for 6 consecutive years, with 2.22 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO fell 408.82% year-over-year to 2.22 in Q2 2026; TTM through Jun 2026 was 1.21, a 409.24% decrease from a year earlier, with the FY2025 full-year figure at 1.03, down 218.92% from the prior year.
- EV to CFO was 2.22 for Q2 2026 at Molecular Partners Ag, up from 3280.11 in the prior quarter.
- Over five years, EV to CFO peaked at 2396.65 in Q1 2024 and troughed at 3280.11 in Q1 2026.
- A 5-year average of 26.23 and a median of 0.31 in 2022 frame the typical range for EV to CFO.
- Across the five-year window, EV to CFO jumped 127506.87% in 2024 and slumped 466.1% in 2026, its largest moves.
- Over 5 years, EV to CFO stood at 0.18 in 2022, then soared by 1878.41% to 3.26 in 2023, then slumped by 142.9% to 1.4 in 2024, then sank by 205.39% to 4.27 in 2025, then soared by 47.98% to 2.22 in 2026.
- The last three EV to CFO figures came in at 2.22 (Q2 2026), 3280.11 (Q1 2026), and 4.27 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Molecular Partners Ag | 156.54 Mn | 156.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.22 |
| Mar 31, 2026 | -3,280.11 |
| Dec 31, 2025 | -4.27 |
| Sep 30, 2025 | -1.54 |
| Jun 30, 2025 | -0.44 |
| Mar 31, 2025 | -579.42 |
| Dec 31, 2024 | -1.40 |
| Sep 30, 2024 | -1.25 |
| Jun 30, 2024 | -2.45 |
| Mar 31, 2024 | 2,396.65 |
| Dec 31, 2023 | 3.26 |
| Sep 30, 2023 | 5.67 |
| Jun 30, 2023 | 1.25 |
| Mar 31, 2023 | 1.88 |
| Dec 31, 2022 | -0.18 |
| Sep 30, 2022 | 0.39 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 1,935.75 |
| Dec 31, 2021 | -4.82 |
| Sep 30, 2021 | 7.06 |